Strides Pharma gets tentative nod from USFDA for pain relieving drug - (The Economic Times via NewsPoints Desk)

  • Strides Pharma said it received tentative FDA approval for the nonsteroidal anti-Inflammatory drug diclofenac to relieve pain, reported The Economic Times.

  • The product is a generic version of Assertio Therapeutics' Zipsor capsules.

  • According to the news source, diclofenac is part of Strides' "niche and small-volume product portfolio" with limited competition in the US market.

  • The product will be manufactured at the company's oral dosage facility in Bengaluru, India.

To read more NewsPoints articles, click here.